{"id":184386,"date":"2020-07-03T18:18:35","date_gmt":"2020-07-03T18:18:35","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=184386"},"modified":"2020-07-03T18:18:35","modified_gmt":"2020-07-03T18:18:35","slug":"comisia-europeana-autorizeaza-un-prim-tratament-impotriva-covid-19","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=184386","title":{"rendered":"Comisia European\u0103 autorizeaz\u0103 un prim tratament \u00eempotriva COVID-19"},"content":{"rendered":"<p>\nComisia European\u0103 a acordat vineri o autoriza\u0163ie de introducere pe pia\u0163\u0103 condi\u0163ionat\u0103 pentru medicamentul Remdesivir, care devine astfel primul medicament autorizat la nivelul UE pentru tratamentul \u00eempotriva COVID-19.<\/p>\n<p>\nAutorizarea, \u00een cadrul unei proceduri accelerate, survine \u00een urma unei recomand\u0103ri din partea Agen\u0163iei Europene pentru Medicamente (EMA), urmat\u0103 de o aprobare din partea statelor membre.<\/p>\n<p>\n\u201eProtec\u0163ia s\u0103n\u0103t\u0103\u0163ii publice este o prioritate-cheie a CE \u015fi, ca atare, datele privind Remdesivir au fost evaluate \u00eentr-un interval de timp excep\u0163ional de scurt prin intermediul unei proceduri de examinare continu\u0103, o abordare utilizat\u0103 de EMA \u00een situa\u0163ii de urgen\u0163\u0103 \u00een materie de s\u0103n\u0103tate public\u0103 pentru a evalua datele pe m\u0103sur\u0103 ce acestea devin disponibile\u201d, a ar\u0103tat CE.<\/p>\n<p>\nAcest lucru a permis acordarea rapid\u0103 a autoriza\u0163iei \u00een contextul crizei provocate de coronavirus, \u00een termen de o s\u0103pt\u0103m\u00e2n\u0103 de la recomandarea EMA, \u00een compara\u0163ie cu termenul obi\u015fnuit de 67 de zile.<\/p>\n<p>\nComisarul pentru s\u0103n\u0103tate \u015fi siguran\u0163\u0103 alimentar\u0103, Stella Kyriakides, a declarat c\u0103 autorizarea unui prim medicament pentru a trata COVID-19 reprezint\u0103 un mare pas \u00eenainte \u00een lupta \u00eempotriva noului coronavirus.<\/p>\n<p>\n\u201eAcord\u0103m aceast\u0103 autoriza\u0163ie la mai pu\u0163in de o lun\u0103 de la depunerea cererii, dovad\u0103 clar\u0103 a hot\u0103r\u00e2rii UE de a r\u0103spunde rapid de fiecare dat\u0103 c\u00e2nd tratamente noi devin disponibile. Nu vom precupe\u0163i niciun efort pentru a asigura tratamente sau vaccinuri eficiente \u00eempotriva coronavirusului\u201d, a spus Kyriakides.<\/p>\n<p>\nMedicamentul autorizat Remdesivir dispune acum de o autoriza\u0163ie de introducere pe pia\u0163\u0103 condi\u0163ionat\u0103, unul dintre mecanismele de reglementare ale UE create pentru a facilita accesul rapid la medicamente care r\u0103spund unei nevoi medicale nesatisf\u0103cute, inclusiv la cele pentru situa\u0163ii de urgen\u0163\u0103 ca r\u0103spuns la amenin\u0163\u0103ri la adresa s\u0103n\u0103t\u0103\u0163ii publice, cum ar fi actuala pandemie.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Comisia European\u0103 a acordat vineri o autoriza\u0163ie de introducere pe pia\u0163\u0103 condi\u0163ionat\u0103 pentru medicamentul Remdesivir, care devine astfel primul medicament autorizat la nivelul UE pentru tratamentul \u00eempotriva COVID-19. Autorizarea, \u00een cadrul unei proceduri accelerate, survine \u00een urma unei recomand\u0103ri din partea Agen\u0163iei Europene pentru Medicamente (EMA), urmat\u0103 de o aprobare din partea statelor membre. \u201eProtec\u0163ia [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[1774,7371,46210,32260,12923],"class_list":["post-184386","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-ce","tag-comisia-europeana","tag-covid","tag-medicament","tag-tratament"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/184386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=184386"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/184386\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=184386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=184386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=184386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}